- Associated Press•12 hours ago
On a per-share basis, the Ardsley, New York-based company said it had a loss of 40 cents. Earnings, adjusted for costs related to mergers and acquisitions and stock option expense, were 7 cents per share. ...
- Barrons.com•2 days ago
Guggenheim Securities Acorda Therapeutics, Alkermes and Alexion Pharmaceuticals report second-quarter earnings on Thursday, July 28, before the market opens. We suspect Acorda (ticker: ACOR) (rated at ...
Acorda Therapeutics, Inc.NasdaqGS
After hours: 24.950.00 (0.00%) as of 4:56 PM EDT
|Bid||24.10 x 100|
|Ask||26.00 x 200|
|52wk Range||23.85 - 43.63|
|Day's Range||24.00 - 26.20|
|Avg Vol (3m)||538,106|
As of 4:00 PM EDT. Market closed.